201 related articles for article (PubMed ID: 30045005)
1. Structural and molecular adaptations to dexamethasone and unacylated ghrelin administration in skeletal muscle of the mice.
Canepari M; Agoni V; Brocca L; Ghigo E; Gnesi M; Minetto MA; Bottinelli R
J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 30045005
[TBL] [Abstract][Full Text] [Related]
2. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
[TBL] [Abstract][Full Text] [Related]
3. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
Baehr LM; Furlow JD; Bodine SC
J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
[TBL] [Abstract][Full Text] [Related]
4. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
5. 20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy
Wang M; Jiang R; Liu J; Xu X; Sun G; Zhao D; Sun L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649814
[TBL] [Abstract][Full Text] [Related]
6. Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice.
Allen DL; Cleary AS; Lindsay SF; Loh AS; Reed JM
J Appl Physiol (1985); 2010 Sep; 109(3):692-701. PubMed ID: 20595541
[TBL] [Abstract][Full Text] [Related]
7. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
8. Mountain ginseng inhibits skeletal muscle atrophy by decreasing muscle RING finger protein-1 and atrogin1 through forkhead box O3 in L6 myotubes.
Seok YM; Yoo JM; Nam Y; Kim J; Kim JS; Son JH; Kim HJ
J Ethnopharmacol; 2021 Apr; 270():113557. PubMed ID: 33161026
[TBL] [Abstract][Full Text] [Related]
9. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.
Watson ML; Baehr LM; Reichardt HM; Tuckermann JP; Bodine SC; Furlow JD
Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1210-20. PubMed ID: 22354783
[TBL] [Abstract][Full Text] [Related]
10. The administration of Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy in mice.
Kim JW; Ku SK; Han MH; Kim KY; Kim SG; Kim GY; Hwang HJ; Kim BW; Kim CM; Choi YH
Int J Mol Med; 2015 Jul; 36(1):29-42. PubMed ID: 25955031
[TBL] [Abstract][Full Text] [Related]
11. Preventive Effects of Schisandrin A, A Bioactive Component of
Yeon M; Choi H; Jun HS
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32354126
[TBL] [Abstract][Full Text] [Related]
12. Identification of a KLF5-dependent program and drug development for skeletal muscle atrophy.
Liu L; Koike H; Ono T; Hayashi S; Kudo F; Kaneda A; Kagechika H; Manabe I; Nakashima T; Oishi Y
Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34426497
[TBL] [Abstract][Full Text] [Related]
13. PKB signaling and atrogene expression in skeletal muscle of aged mice.
Gaugler M; Brown A; Merrell E; DiSanto-Rose M; Rathmacher JA; Reynolds TH
J Appl Physiol (1985); 2011 Jul; 111(1):192-9. PubMed ID: 21551011
[TBL] [Abstract][Full Text] [Related]
14. Conessine Treatment Reduces Dexamethasone-Induced Muscle Atrophy by Regulating MuRF1 and Atrogin-1 Expression.
Kim H; Jang M; Park R; Jo D; Choi I; Choe J; Oh WK; Park J
J Microbiol Biotechnol; 2018 Apr; 28(4):520-526. PubMed ID: 29724080
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone exacerbates cisplatin-induced muscle atrophy.
Sakai H; Kimura M; Tsukimura Y; Yabe S; Isa Y; Kai Y; Sato F; Kon R; Ikarashi N; Narita M; Chiba Y; Kamei J
Clin Exp Pharmacol Physiol; 2019 Jan; 46(1):19-28. PubMed ID: 30137654
[TBL] [Abstract][Full Text] [Related]
16. High-intensity resistance training attenuates dexamethasone-induced muscle atrophy.
Krug AL; Macedo AG; Zago AS; Rush JW; Santos CF; Amaral SL
Muscle Nerve; 2016 May; 53(5):779-88. PubMed ID: 26355638
[TBL] [Abstract][Full Text] [Related]
17. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
18. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
Krawiec BJ; Nystrom GJ; Frost RA; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1555-67. PubMed ID: 17264220
[TBL] [Abstract][Full Text] [Related]
20. A novel hindlimb immobilization procedure for studying skeletal muscle atrophy and recovery in mouse.
Caron AZ; Drouin G; Desrosiers J; Trensz F; Grenier G
J Appl Physiol (1985); 2009 Jun; 106(6):2049-59. PubMed ID: 19342435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
